Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols - PubMed (original) (raw)

Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols

J Sands et al. Antimicrob Agents Chemother. 1979 Jan.

Abstract

Unsaturated monoglycerides and alcohols of chain lengths of 16 or 18 carbons were found to be extremely potent inactivators of two enveloped viruses, herpes simplex virus type 2 and bacteriophage phi6. The lipid-containing bacteriophage PM2 was also inactivated by some of these amphiphilic molecules. Treatment of herpes simplex virus type 2 with these compounds at concentrations as low as 0.2 muM reduced virus survival to 50% in 30 min, making these agents the most potent inactivators of herpes simplex viruses discovered that are not cytotoxic to mammalian cells. Detailed characterizations of the effects of unsaturated monoglycerides and alcohols on bacteriophages phi6 and PM2 showed that the inactivated phi6 virion remained nearly intact but that PM2 was almost completely disrupted by the inactivating treatment. Some of the compounds inactivate the viruses even at low temperature (0 degrees C). Excess amounts of diglycerides and phospholipids interfere with the inactivating abilities of some of the unsaturated monoglycerides and alcohols against phi6 and PM2. Our findings suggest that the unsaturated monoglycerides and some of the unsaturated alcohols should be further studied as potential antiviral agents, particularly for application to herpesvirus-infected areas of the skin and accessible epithelium.

PubMed Disclaimer

Similar articles

• Inactivation of lipid-containing viruses by long-chain alcohols.
  Snipes W, Person S, Keller G, Taylor W, Keith A. Snipes W, et al. Antimicrob Agents Chemother. 1977 Jan;11(1):98-104. doi: 10.1128/AAC.11.1.98. Antimicrob Agents Chemother. 1977. PMID: 189684 Free PMC article.
• Enveloped virus inactivation by fatty acid derivatives.
  Sands JA, Auperin LD, Reinhardt A. Sands JA, et al. Antimicrob Agents Chemother. 1979 Jan;15(1):134-6. doi: 10.1128/AAC.15.1.134. Antimicrob Agents Chemother. 1979. PMID: 218498 Free PMC article.
• Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.
  Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. Thormar H, et al. Antimicrob Agents Chemother. 1987 Jan;31(1):27-31. doi: 10.1128/AAC.31.1.27. Antimicrob Agents Chemother. 1987. PMID: 3032090 Free PMC article.
• 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
  Kumar R. Kumar R. Curr Med Chem. 2004 Oct;11(20):2749-66. doi: 10.2174/0929867043364388. Curr Med Chem. 2004. PMID: 15544474 Review.
• Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells.
  Su X, Wang Q, Wen Y, Jiang S, Lu L. Su X, et al. Front Microbiol. 2020 May 25;11:1063. doi: 10.3389/fmicb.2020.01063. eCollection 2020. Front Microbiol. 2020. PMID: 32523582 Free PMC article. Review.

Cited by

• Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.
  Das UN. Das UN. Arch Med Sci. 2021 Apr 23;19(5):1327-1359. doi: 10.5114/aoms/135703. eCollection 2023. Arch Med Sci. 2021. PMID: 37732033 Free PMC article.
• Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.
  Das UN. Das UN. Biomolecules. 2021 Dec 14;11(12):1873. doi: 10.3390/biom11121873. Biomolecules. 2021. PMID: 34944517 Free PMC article. Review.
• Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19.
  Manickam M, Meenakshisundaram S, Pillaiyar T. Manickam M, et al. Arch Pharm (Weinheim). 2022 Mar;355(3):e2100367. doi: 10.1002/ardp.202100367. Epub 2021 Nov 21. Arch Pharm (Weinheim). 2022. PMID: 34802171 Free PMC article. Review.
• The Infectious Bronchitis Coronavirus Pneumonia Model Presenting a Novel Insight for the SARS-CoV-2 Dissemination Route.
  Nefedova E, Koptev V, Bobikova AS, Cherepushkina V, Mironova T, Afonyushkin V, Shkil N, Donchenko N, Kozlova Y, Sigareva N, Davidova N, Bogdanchikova N, Pestryakov A, Toledano-Magaña Y. Nefedova E, et al. Vet Sci. 2021 Oct 18;8(10):239. doi: 10.3390/vetsci8100239. Vet Sci. 2021. PMID: 34679068 Free PMC article.
• Tear Lipocalin and Lipocalin-Interacting Membrane Receptor.
  Glasgow BJ. Glasgow BJ. Front Physiol. 2021 Aug 19;12:684211. doi: 10.3389/fphys.2021.684211. eCollection 2021. Front Physiol. 2021. PMID: 34489718 Free PMC article.

References

1. 1. Science. 1975 Apr 4;188(4183):64-6 - PubMed
2. 1. Antimicrob Agents Chemother. 1977 Jan;11(1):98-104 - PubMed
3. 1. Antimicrob Agents Chemother. 1978 Feb;13(2):199-204 - PubMed
4. 1. J Virol. 1978 Feb;25(2):479-85 - PubMed
5. 1. J Gen Virol. 1976 Aug;32(2):249-59 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations